Upload
putu-yustiantara
View
235
Download
0
Embed Size (px)
Citation preview
8/18/2019 GMP steril WHO
1/62
Module 14 | Slide 1 of 62 January 2006
Annex 6. TRS 902, 2002
Basic Principles of GMP
Sterile Pharmaceutical Products
8/18/2019 GMP steril WHO
2/62
Module 14 | Slide 2 of 62 January 2006
Sterile Production
Objectives
To review basic GMP requirements in the manufacture of sterile
pharmaceutical products
To review air classifications for activities related to themanufacture of sterile products
To review the different types of sterilization methods
To review quality assurance aspects in the manufacture and
control of sterile products
To consider current issues applicable in your country
8/18/2019 GMP steril WHO
3/62
Module 14 | Slide 3 of 62 January 2006
Sterile Production
!P Re"uirements #or Sterile Products
Additional rather than replacement
Specific points relating to minimizing risks of contamination
microbiological
particulate matter
pyrogen
8/18/2019 GMP steril WHO
4/62
Module 14 | Slide 4 of 62 January 2006
Sterile Production
eneral $onsiderations
Production in clean areas
Appropriate standard of cleanliness
iltered air supplied
Airlocks for entry personnel and/or equipment
materials
Separate areas for operations
component preparation (containers and closures)
product preparation
filling, sterilization, etc.1.1 – 1-2
8/18/2019 GMP steril WHO
5/62
Module 14 | Slide 5 of 62 January 2006
9.1 – 9.6
Sterile Production
Premises !esign
avoid unnecessary entry of supervisors and control personnel operations observed from outside
"n clean areas# all e$posed surfaces
smooth, impervious, unbrokenminimize shedding and accumulation of particles,
microorganisms
permit cleaning and disinfection
no uncleanable recesses, ledges, shelves, cupboards,
equipment sliding doors undesirable
false ceilings sealed
8/18/2019 GMP steril WHO
6/62
Module 14 | Slide 6 of 62 January 2006
9.6.
Sterile Production
Premises %continued& "n clean areas# all e$posed surfaces %'&
proper installation of pipes and ducts, no recesses,
no unsealed openings
sinks and drains avoided, and excluded in Grade and !areas
( "here installed, design, location, maintenance
( effective cleanable traps
( air breaks preventing backflo"
( floor channels open and easily cleanable
8/18/2019 GMP steril WHO
7/62
Module 14 | Slide 7 of 62 January 2006
9.7 – 9.9
Sterile Production
Premises %continued&)hanging rooms
designed as airlocks
effective flushing "ith filtered air
separate rooms for entry and exit desirable
hand "ashing facilities
interlocking system for doors
visual and/or audible "arning system
*se filtered air supply to maintain pressure cascade
Pressure differential appro$imately +, to +- Pascals .one of greatest risk ( immediate environment
8/18/2019 GMP steril WHO
8/62
Module 14 | Slide 8 of 62 January 2006
9.9 – 9.12
Sterile Production
Premises %continued&Pathogenic# highly to$ic# radioactive materials
Pressure cascade may be different
!econtamination procedures ( air# equipment# garments
/ualification including airflow patterns
no risk to the product
0arning system to indicate failure in air supply
Pressure indicators ( results regularly recorded
1estricted access ( e2g2 use of barriers
8/18/2019 GMP steril WHO
9/62
Module 14 | Slide 9 of 62 January 2006
10.1 – 10.5
Sterile Production
%"ui&ment)onveyer belts
3ffective sterilization of equipment
Maintenance and repairs from outside the clean area
if taken apart, resterilized before use
use clean instruments and tools
Planned maintenance# validation and monitoring
equipment, air filtration systems, sterilizers, "ater
treatment systems
8/18/2019 GMP steril WHO
10/62
Module 14 | Slide 10 of 62 January 2006
10.6
Sterile Production
%"ui&ment %continued&0ater treatment plants and distribution system
design, construction, maintenance
operation and design capacity
testing programme
0ater for "n4ection %0"&
produced, stored, distributed # prevention of gro"th of
microorganisms
constant circulation at temperature above $%, or not more
than & degrees 'elsius
8/18/2019 GMP steril WHO
11/62
Module 14 | Slide 11 of 62 January 2006
Sterile Production
%nvironmental !onitorin' ( )
!icrobiolo'ical
Air samples
Surface swabs
Personnel swabs
8/18/2019 GMP steril WHO
12/62
Module 14 | Slide 12 of 62 January 2006
Sterile Production
%nvironmental !onitorin' * ))
Ph+sical
Particulate matter
!ifferential pressures
Air changes# airflow patterns
)lean up time5recovery
ilter integrity
Temperature and relative humidity
Airflow velocity
8/18/2019 GMP steril WHO
13/62
Module 14 | Slide 13 of 62 January 2006
Sterile Production
Sanitation
requent# thorough cleaning of areas necessary
0ritten programme
1egular monitoring to detect resistant strains of microorganisms
)hemical disinfection
Monitoring of disinfectants and detergents
!ilutions
clean containers, stored for defined periods of time
terilized before use, "hen used in Grade or ! areas3.1 – 3.2
8/18/2019 GMP steril WHO
14/62
Module 14 | Slide 14 of 62 January 2006
Sterile Production
Sanitation %continued&
Monitoring of clean areas
Monitoring of personnel and surfaces after critical operations
requent monitoring in areas where aseptic operations are
carried out
settle plates, volumetric air samples, surface sampling
(s"abs and contact plates)
sampling methods should not contaminate the area
1esults considered when batch release is done3.3
8/18/2019 GMP steril WHO
15/62
Module 14 | Slide 15 of 62 January 2006
Sterile Production
Sanitation %continued& 6imits of detection established
Alert and action# and monitoring trends of air quality
Table +2 6imits for microbial contamination %information only& 3.
8/18/2019 GMP steril WHO
16/62
Module 14 | Slide 16 of 62 January 2006
!.1 – !.3
Sterile Production
PersonnelMinimum number of personnel in clean areas
especially during aseptic processing
"nspections and controls from outside
Training to all including cleaning and maintenance staff initial and regular
manufacturing, hygiene, microbiology
Special cases
supervision in case of outside staff decontamination procedures (e.g. staff "ho "orked "ith
animal tissue materials)
8/18/2019 GMP steril WHO
17/62
Module 14 | Slide 17 of 62 January 2006
!. – !.6
Sterile Production
Personnel %continued&
7igh standards of hygiene and cleanliness
Periodic health checks
8o shedding of particles
8o introduction of microbiological hazards
8o outdoor clothing
)hanging and washing procedure
8o watches# 4ewellery and cosmetics
8/18/2019 GMP steril WHO
18/62
Module 14 | Slide 18 of 62 January 2006
!.7
Sterile Production
Personnel %continued&)lothing of appropriate quality9Grade
( hair, beard, moustache covered ( protective clothing and shoes
Grade ' ( hair, beard, moustache covered ( single or *+piece suit (covering "rists, high neck), shoes ( no fibres to be shed
Grade and !
headgear, beard and moustache covered, masks, glovesnot shedding fibres, and retain particles shed byoperators
8/18/2019 GMP steril WHO
19/62
Module 14 | Slide 19 of 62 January 2006
!.! – !.9
Sterile Production
Personnel %continued&:utdoor clothing not in change rooms leading to Grade ; and )
rooms
)hange at every working session# or once a day %if supportive
data&
)hange gloves and masks at every working session
!isinfect gloves during operations
0ashing of garments ( separate laundry facility8o damage# and according to validated procedures
8/18/2019 GMP steril WHO
20/62
Module 14 | Slide 20 of 62 January 2006
Sterile Production
rou& session
8/18/2019 GMP steril WHO
21/62
Module 14 | Slide 21 of 62 January 2006
Sterile Production
Possible )ssues Poor design of the building
Poor design of the systems# e2g2 water# 7=A)
low of personnel
low of material
8o validation or qualification
:ld facilities not complying with current requirements
8/18/2019 GMP steril WHO
22/62
Module 14 | Slide 22 of 62 January 2006
Sterile Production
Possible )ssues %continued&
Particulate levels5microorganisms
!ifferential pressures
Air changes
Temperature5humidity
8/18/2019 GMP steril WHO
23/62
Module 14 | Slide 23 of 62 January 2006
Sterile Production
T-o cate'ories o# manu#acturin' o&erations
Terminally sterilized
prepared, filled and sterilized
Aseptic preparation
some or all stages
1.3
8/18/2019 GMP steril WHO
24/62
Module 14 | Slide 24 of 62 January 2006
Sterile Production
!anu#acture o# sterile &re&arations
)lassification of clean areas
Manufacturing operation in an appropriate environment
cleanliness level
Minimize risks ( particulate and microbiological contamination (
product and material
Meet classification >at rest>
(-hat is completed installation, equipment installed and
operating, but no operating personnel present)
.1
8/18/2019 GMP steril WHO
25/62
Module 14 | Slide 25 of 62 January 2006
Sterile Production
!anu#acture o# sterile &re&arations or sterile pharmaceutical preparations9
Grade A
local zone, high risk operations, e.g. filling, aseptic
connectionsusually 0 systems used
Grade ;
background environment to Grade (in case of aseptic
preparation and filling)
Grade ) and Grade !
'lean areas for less critical operations.1
8/18/2019 GMP steril WHO
26/62
Module 14 | Slide 26 of 62 January 2006
Air Classifcation System
Sterile Production
3.1
8/18/2019 GMP steril WHO
27/62
Module 14 | Slide 27 of 62 January 2006
Sterile Production
!anu#acture o# sterile &re&arations
To reach Grade ;# ) and !# the number of air changes should beappropriate to the size of the area# number of personnel#equipment present
Minimum of ', air changes per hour
)lean?up time about +- ( ', minutes
Good airflow pattern in the area
73PA filtered air
Suitable methods to determine particulate matter and microe.g. 1, 23, 4apan, .1 – .2.
8/18/2019 GMP steril WHO
28/62
Module 14 | Slide 28 of 62 January 2006
Sterile Production
!anu#acture o# sterile &re&arations)ontrol particulate during operation
Monitoring during operation
Alert and action limits for particulate and micro
Action taken when e$ceeded
Area grades should be proven %e2g2 validation runs# media fills#
environment# time limits ? based on microbiologicalcontamination5bioburden found&.3 – .5
8/18/2019 GMP steril WHO
29/62
Module 14 | Slide 29 of 62 January 2006
Airborne particulate classifcation
Sterile Production
.1
8/18/2019 GMP steril WHO
30/62
Module 14 | Slide 30 of 62 January 2006
.15 – .16" .20 – .21
Sterile Production
Processin'
Minimize contamination ? all stages including before sterilization
and during processing
8o unsuitable materials# e2g2 live microbiological organisms
Minimize activities
staff movement controlled and methodical
avoid shedding of particles
Temperature and humidity comfortable
)ontainers and materials in the area
8/18/2019 GMP steril WHO
31/62
Module 14 | Slide 31 of 62 January 2006
.17" .1!" .2!
Sterile Production
Processin' =alidation ( should not compromise the processes Aseptic process validation9 sterile media fill %@broth fills&simulate actual operation # intimate as closely as possiblesimulate "orst expected conditionuse appropriate medium/mediasufficient number of units, e.g. equal to batch size (small batches)
( acceptable limit ( investigations
revalidation5 periodic and after change8ew processing procedures validated
revalidation after significant changesand regular intervals
8/18/2019 GMP steril WHO
32/62
Module 14 | Slide 32 of 62 January 2006
.19
Sterile Production
Processin'
0ater sources# water treatment systems and treated water
Monitored regularly
chemicalsbiological contamination
endotoxin
0ater specification
1ecords of results and action taken
8/18/2019 GMP steril WHO
33/62
Module 14 | Slide 33 of 62 January 2006
.22 – .23
Sterile Production
Processin')omponents# bulk product containers and equipment
fibre generation
no recontamination after final cleaning
stage properly identified
sterilized "hen used in aseptic areas
*sed in clean areas# passed through double?ended sterilizers or
use triple wrapping
Gas used to purge solution or blanket a product ( passedthrough a sterilizing filter
8/18/2019 GMP steril WHO
34/62
Module 14 | Slide 34 of 62 January 2006
.26" 5.3
Sterile Production
Processin' ;ioburden monitored
products5 before sterilization
"orking limits established
solutions to be filtered before filling (especially 678) pressure release outlets # hydrophobic microbiological air
filters
Starting materials ( microbiological contamination should be
minimal
Monitored as per specification
8/18/2019 GMP steril WHO
35/62
Module 14 | Slide 35 of 62 January 2006
.23 - .2
Sterile Production
Processin' Time intervals com&onents, bul/ containers, e"ui&ment
0ashing and drying and sterilizationB and sterilization and use
as short as possible
time limit validated
Time intervals &roduct
Start of preparation of solution and sterilization %filtration&
as short as possiblemaximum time set for each product
8/18/2019 GMP steril WHO
36/62
Module 14 | Slide 36 of 62 January 2006
Sterile Production
rou& session 2)onsidering the same factory as in the previous group session#
discuss the process of sterilization
6ist all the items that will need to be sterilized %and indicate the
choice of sterilization process&
0hat are the key features you should find in each sterilization
situationC
!iscuss the relevance# need# and the e$tent of qualification andvalidation required
8/18/2019 GMP steril WHO
37/62
Module 14 | Slide 37 of 62 January 2006
Sterile Production
Possible )ssues
Autoclave ? no pressure gauge
Autoclave ? no temperature recorder
Autoclave ? superheated steam)lean room ? pressure differentials
3$posure for settle plates
"nterlocks turned off
1usty 6aminar airflow cabinets73PA filters not checked regularly
8/18/2019 GMP steril WHO
38/62
Module 14 | Slide 38 of 62 January 2006
5.1 – 5. 2
Sterile Production
SteriliationMethods of sterilization
moist or dry heat
irradiation (ionizing radiation)
sterilizing gaseous agents (e.g. ethylene oxide)
filtration "ith subsequent aseptic filling
0henever possible9 terminal sterilization by heat in their final
container ? method of choice
8/18/2019 GMP steril WHO
39/62
Module 14 | Slide 39 of 62 January 2006
5. – 5.5
Sterile Production
Steriliation=alidationall sterilization processesspecial attention "hen non+pharmacopoeial methods are
used non+aqueous or oily solutions
;efore the method is adopted ( its suitability and efficacydemonstrated with desired conditionsall parts of the load each type of load physical measurements and biological indicators ("here
appropriate)verified at least annually and after change records maintained
8/18/2019 GMP steril WHO
40/62
8/18/2019 GMP steril WHO
41/62
Module 14 | Slide 41 of 62 January 2006
5.! - 5.9
Sterile Production
Steriliation!ifferentiation between sterilized and not?yet?sterilized products
3ach basket5tray or other carrier# properly labelled
name of material
batch number sterilization status
*se of autoclave tape
Sterilization records for each run ( approved as part of the batch
release procedure
8/18/2019 GMP steril WHO
42/62
Module 14 | Slide 42 of 62 January 2006
6
Sterile Production
Terminal Steriliation
Sterilization by heat
Sterilization by moist heat
Sterilization by dry heat
Sterilization by radiation
Sterilization by gases and fumigants
8/18/2019 GMP steril WHO
43/62
Module 14 | Slide 43 of 62 January 2006
6.2 – 6.3
Sterile Production
Terminal SteriliationSterilization by heat
1ecording of each cycle# e2g2 time and temperature chart
temperature5 validated coolest part
check from second independent probe
additional chemical or biological indicators
7eating phase9 sufficient time for the whole load
determined for each load
)ooling phase9 after sterilization cycle
precautions to prevent contamination
sterilized cooling fluid/gas
8/18/2019 GMP steril WHO
44/62
Module 14 | Slide 44 of 62 January 2006
6. – 6.6
Sterile Production
Terminal Steriliation
Sterilization by moist heat %heating in an autoclave&
0ater?wettable materials only# and aqueous formulations
Temperature# time and pressure monitored
Temperature recorder independent of the controller
"ndependent temperature indicator
!rain ( temperature recorded from this position
1egular leak test when vacuum is part of the cycle
Material allows for removal of air and penetration of steam
All parts of the load in contact with steam/uality of the steam ( no contamination
8/18/2019 GMP steril WHO
45/62
Module 14 | Slide 45 of 62 January 2006
6.7
Sterile Production
Terminal Steriliation
Sterilization by dry heat
or non?aqueous liquids# dry powders
Air circulation in the chamber
Positive pressure in chamber to prevent entry of non?sterile air
73PA filtered air supplied
0hen removing pyrogens# challenge tests
validation (using endotoxins)
8/18/2019 GMP steril WHO
46/62
Module 14 | Slide 46 of 62 January 2006
6.! – 6.10
Sterile Production
Terminal SteriliationSterilization by radiation
Suitable for heat?sensitive materials and productsconfirm suitability of method for material ultraviolet irradiation not acceptable
)ontracting service ( ensure validation status# responsibilities
Measurement of dose during procedure
!osimeters independent of dose ratequantitative measurement number, location and calibration time+limit
;iological indicators only as additional control
1adiation sensitive colour discs
8/18/2019 GMP steril WHO
47/62
Module 14 | Slide 47 of 62 January 2006
6.10 – 6.13
Sterile Production
Terminal SteriliationSterilization by radiation %'&
"nformation forms part of the batch record
=alidation to cover effects of variation in density of
packages7andling procedures to prevent misidentification of
irradiated and non?irradiated materials
3ach package to have a radiation?sensitive indicator
Total radiation dose administered within a predeterminedperiod of time
8/18/2019 GMP steril WHO
48/62
8/18/2019 GMP steril WHO
49/62
Module 14 | Slide 49 of 62 January 2006
6.21
Sterile Production
Terminal Steriliation Monitoring of each cycle with biological indicators time, pressure
temperature, humidity
gas concentration
Sterilization by gases and fumigants %'&
Post?sterilization storage ( controlled manner
ventilated conditions
defined limit of residual gas
validated process Safety and to$icity issues
8/18/2019 GMP steril WHO
50/62
Module 14 | Slide 50 of 62 January 2006
Sterile Production
Terminall+ sterilied &roducts
.6 – .7
8/18/2019 GMP steril WHO
51/62
Module 14 | Slide 51 of 62 January 2006
Sterile Production
Terminall+ sterilied &roducts
.! – .9
8/18/2019 GMP steril WHO
52/62
Module 14 | Slide 52 of 62 January 2006
Sterile Production
Ase&tic &rocessin' and steriliation b+ #iltration
Aseptic processing
:b4ective is to maintain the sterility of a product# assembled
from sterile components
:perating conditions so as to prevent microbial contamination
0hat do you think are the aspects that require careful attentionC
7.1 – 7.2
8/18/2019 GMP steril WHO
53/62
Module 14 | Slide 53 of 62 January 2006
Sterile Production
Ase&tic &rocessin' and steriliation b+ #iltration Aseptic processing %'&
)areful attention to9
3nvironment
Personnel
)ritical surfaces
)ontainer5closure sterilization
Transfer proceduresMa$imum holding period before filling
7.3
8/18/2019 GMP steril WHO
54/62
Module 14 | Slide 54 of 62 January 2006
Sterile Production
Ase&tic &re&aration
.10" .11" .1
8/18/2019 GMP steril WHO
55/62
Module 14 | Slide 55 of 62 January 2006
Sterile Production
Ase&tic &re&aration
.10 – .13
8/18/2019 GMP steril WHO
56/62
Module 14 | Slide 56 of 62 January 2006
Sterile Production
Steriliation b+ 1iltration Through a sterile filter of ,#'' Dm or less# into previously
sterilized containers
remove bacteria and moulds
not all viruses or mycoplasmas)onsider complementing with some degree of heat treatment
!ouble filter layer or second filtration advisable# 4ust before filling? no fibre shedding or asbestos filters
ilter integrity testing immediately after use
also before use if possible
7. – 7.7
8/18/2019 GMP steril WHO
57/62
8/18/2019 GMP steril WHO
58/62
St il P d ti
8/18/2019 GMP steril WHO
59/62
Module 14 | Slide 59 of 62 January 2006
Sterile Production
5ualit+ $ontrolSamples for sterility testing should be representative
rom parts of the batch# most at risk
aseptic filling + at beginning and end of batch filling, and afterinterruptions
heat sterilized # coolest part of the load
Sterility of the batch ensured through validation
validated sterilization cycle
media fill
Sterility test procedure as per pharmacopoeia# and validated for
each product;atch processing records# sterility testing records# environmental
records should be reviewed2.1 -2.2
St il P d ti
8/18/2019 GMP steril WHO
60/62
Module 14 | Slide 60 of 62 January 2006
Sterile Production
5ualit+ $ontrol3ndoto$in testing for in4ectable products
"ater for inection, intermediate and finished product
Always for large volume infusion solutions
Pharmacopoeia method# validated for each product
ailure of the test ( investigation
)orrective action
2.3
St il P d ti
8/18/2019 GMP steril WHO
61/62
Module 14 | Slide 61 of 62 January 2006
Sterile Production
1inishin' o# &roducts)ontainers closed by means of validated methods Samples checked for integrity
Maintenance of vacuum %where applicable& checked
Parenteral products inspected individually
=isual inspection under suitable and controlled conditions illumination and background
eyesight checks of operators
allo"ed frequent breaks
:ther methods
validated, and equipment performance checked at intervals
results recorded 11.1 – 11.3
St il P d ti
8/18/2019 GMP steril WHO
62/62
Sterile Production
rou& session 4)onsidering the same factory as in the previous group sessions#
devise a plan for monitoring of the facility
6ist the parameters to be tested# tests to be used# acceptance
criteria and frequency of testing